The Code of Conduct for Pharmaceutical Advertising (Code of Conduct) (In Dutch: Gedragscode Geneesmiddelenreclame) has been amended as of 1 July, 2018. The changes come as a response to the amendments to the policy rules providing guidance on the ban of inducements regarding medicinal products, which entered into force 1 April, 2018 (Policy Rules) (In Dutch: Beleidsregels gunstbetoon Geneesmiddelenwet 2018).
The most notable changes of the Policy Rules, and as a result of the Code of Conduct, concern the introduction of a regulatory framework for financial relationships that do not fall under the definition of inducement. Those relationships relate to non-professionals, sponsorship of projects and academic awards.
Furthermore, the scope of exemptions regarding inducements for professionals and regarding hospitality at (scientific) meetings and other events has been slightly altered.